Low FEV1 in Early Adulthood May Be Important in COPD Genesis

Share this content:
Low FEV<sub>1</sub> in Early Adulthood May Be Important in COPD Genesis
Low FEV1 in Early Adulthood May Be Important in COPD Genesis

THURSDAY, July 9, 2015 (HealthDay News) -- Low forced expiratory volume in one second (FEV1) in early adulthood without accelerated decline in FEV1 correlates with later chronic obstructive pulmonary disease (COPD), according to a study published in the July 9 issue of the New England Journal of Medicine.

Peter Lange, M.D., Dr.Med.Sci., from Copenhagen University in Denmark, and colleagues determined the rate of decline in FEV1 over time among participants from three independent cohorts according to the FEV1 at cohort inception and COPD status at study end.

The researchers found that after 22 years of observation, 26 percent of 657 participants who had an FEV1 of less than 80 percent of the predicted value before 40 years of age had COPD, compared with 7 percent of the 2,207 individuals with a baseline FEV1 of at least 80 percent of the predicted value before 40 years of age (P < 0.001). Of the 332 individuals with COPD at the end of the observation period, approximately half had a normal FEV1 before 40 years of age and had rapid decline thereafter (mean decline of 53 ml per year); the remaining half had low FEV1 in early adulthood and a mean decline of 27 ml per year (P < 0.001), despite similar smoking exposure.

"Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD," the authors write.

The study was partially funded by GlaxoSmithKline.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »